Spinal cord lesions in sporadic Parkinson's disease

被引:133
|
作者
Del Tredici, Kelly [1 ]
Braak, Heiko [1 ]
机构
[1] Univ Ulm, Clin Neuroanat Sect, Dept Neurol, Ctr Biomed Res, D-89081 Ulm, Germany
关键词
alpha-Synuclein; Autonomic nervous system; Central nervous system; Incidental Lewy body disease; Intermediolateral nucleus; Lewy body disease; Lewy bodies/neurites; Locus coeruleus; Micturition; Neurodegeneration; Nucleus of Onuf; Pain system; Lower raphe nuclei; Noradrenalin; Renshaw cells; Serotonin; Sporadic Parkinson's disease; Premotor Parkinson's disease; Sacral parasympathetic nucleus; Spinal cord; Synucleinopathy; AUTONOMIC NERVOUS-SYSTEM; LOWER URINARY-TRACT; LEWY BODY DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ALPHA-SYNUCLEIN PATHOLOGY; SUPERFICIAL DORSAL HORN; LAMINA-I NEURONS; LOCUS-COERULEUS; ONUFS NUCLEUS; NONMOTOR SYMPTOMS;
D O I
10.1007/s00401-012-1028-y
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this autopsy-based study, alpha-synuclein immunohistochemistry and lipofuscin pigment-Nissl architectonics in serial sections of 100 mu m thickness were used to investigate the spinal cords and brains of 46 individuals: 28 patients with clinically and neuropathologically confirmed Parkinson's disease, 6 cases with incidental Lewy body disease, and 12 age-matched controls. alpha-Synuclein inclusions (particulate aggregations, Lewy neurites/bodies) in the spinal cord were present between neuropathological stages 2-6 in all cases whose brains were staged for Parkinson's disease-related synucleinopathy. The only individuals who did not have Lewy pathology in the spinal cord were a single stage 1 case (incidental Lewy body disease) and all controls. Because the Parkinson's disease-related lesions were observable in the spinal cord only after Lewy pathology was seen in the brain, it could be concluded that, within the central nervous system, sporadic Parkinson's disease does not begin in the spinal cord. In addition: (1) alpha-Synuclein-immunoreactive axons clearly predominated over Lewy bodies throughout the spinal cord and were visible in medial and anterior portions of the anterolateral funiculus. Their terminal axons formed dense alpha-synuclein-immunoreactive networks in the gray matter and were most conspicuous in the lateral portions of layers 1, 7, and in the cellular islands of layer 9. (2) Notably, this axonopathy increased remarkably in density from cervicothoracic segments to lumbosacral segments of the cord. (3) Topographically, it is likely that the spinal cord alpha-synuclein immunoreactive axonal networks represent descending projections from the supraspinal level setting nuclei (locus coeruleus, lower raphe nuclei, magnocellular portions of the reticular formation). (4) Following the appearance of the spinal cord axonal networks, select types of projection neurons in the spinal cord gray matter displayed alpha-synuclein-immunoreactive inclusions: chiefly, nociceptive neurons of the dorsal horn in layer 1, sympathetic and parasympathetic preganglionic neurons in layer 7, the cellular pools of alpha-motoneurons in layer 9, and the smaller motoneurons in Onuf's nucleus in layer 9 (ventral horn). The spinal cord lesions may contribute to clinical symptoms (e.g., pain, constipation, poor balance, lower urinary tract complaints, and sexual dysfunction) that occur during the premotor and motor phases of sporadic Parkinson's disease.
引用
收藏
页码:643 / 664
页数:22
相关论文
共 50 条
  • [31] New Vistas of the Pathological Process Underlying Sporadic Parkinson's Disease
    Braak, Heiko
    Del Tredici, Kelly
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2008, 15 (02) : 83 - 84
  • [32] Norepinephrine Deficiency in Parkinson's Disease: The Case for Noradrenergic Enhancement
    Espay, Alberto J.
    LeWitt, Peter A.
    Kaufmann, Horacio
    MOVEMENT DISORDERS, 2014, 29 (14) : 1710 - 1719
  • [33] Spinal Cord Microglia in Health and Disease
    Kolos, E. A.
    Korzhevskii, D. E.
    ACTA NATURAE, 2020, 12 (01): : 4 - 17
  • [34] Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
    Dickson, Dennis W.
    Braak, Heiko
    Duda, John E.
    Duyckaerts, Charles
    Gasser, Thomas
    Halliday, Glenda M.
    Hardy, John
    Leverenz, James B.
    Del Tredici, Kelly
    Wszolek, Zbigniew K.
    Litvan, Irene
    LANCET NEUROLOGY, 2009, 8 (12) : 1150 - 1157
  • [35] Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach
    Fuentes, Romulo
    Petersson, Per
    Nicolelis, Miguel A. L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 32 (07) : 1100 - 1108
  • [36] Does spinal cord stimulation improve gait in Parkinson?s disease: A comprehensive review
    Streumer, Jesco
    Selvaraj, Ashok K.
    Kurt, Erkan
    Bloem, Bastiaan R.
    Esselink, Rianne A. J.
    Bartels, Ronald H. M. A.
    Georgiev, Dejan
    Vinke, R. Saman
    PARKINSONISM & RELATED DISORDERS, 2023, 109
  • [37] Is Braak staging valid for all types of Parkinson's disease?
    Jellinger, Kurt A.
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (04) : 423 - 431
  • [38] Distribution of Lewy-related pathology in the brain, spinal cord, and periphery: the population-based Vantaa 85+study
    Raunio, Anna
    Kivisto, Ville
    Kero, Mia
    Tuimala, Jarno
    Savola, Sara
    Oinas, Minna
    Kok, Eloise
    Colangelo, Kia
    Paetau, Anders
    Polvikoski, Tuomo
    Tienari, Pentti J.
    Puttonen, Henri
    Myllykangas, Liisa
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [39] The cellular pathology of Parkinson's disease
    Takahashi, H
    Wakabayashi, K
    NEUROPATHOLOGY, 2001, 21 (04) : 315 - 322
  • [40] The Noradrenergic System in Parkinson's Disease
    Paredes-Rodriguez, Elena
    Vegas-Suarez, Sergio
    Morera-Herreras, Teresa
    De Deurwaerdere, Philippe
    Miguelez, Cristina
    FRONTIERS IN PHARMACOLOGY, 2020, 11